1. Home
  2. HRMY vs SIMO Comparison

HRMY vs SIMO Comparison

Compare HRMY & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • SIMO
  • Stock Information
  • Founded
  • HRMY 2017
  • SIMO 1995
  • Country
  • HRMY United States
  • SIMO Hong Kong
  • Employees
  • HRMY N/A
  • SIMO N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • HRMY Health Care
  • SIMO Technology
  • Exchange
  • HRMY Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • HRMY 2.1B
  • SIMO 2.7B
  • IPO Year
  • HRMY 2020
  • SIMO 2005
  • Fundamental
  • Price
  • HRMY $32.20
  • SIMO $89.77
  • Analyst Decision
  • HRMY Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • HRMY 9
  • SIMO 8
  • Target Price
  • HRMY $55.33
  • SIMO $84.38
  • AVG Volume (30 Days)
  • HRMY 696.1K
  • SIMO 264.3K
  • Earning Date
  • HRMY 10-28-2025
  • SIMO 10-29-2025
  • Dividend Yield
  • HRMY N/A
  • SIMO 2.26%
  • EPS Growth
  • HRMY 58.41
  • SIMO N/A
  • EPS
  • HRMY 3.10
  • SIMO 2.30
  • Revenue
  • HRMY $772,527,000.00
  • SIMO $768,738,000.00
  • Revenue This Year
  • HRMY $20.09
  • SIMO $5.44
  • Revenue Next Year
  • HRMY $16.86
  • SIMO $15.56
  • P/E Ratio
  • HRMY $10.40
  • SIMO $39.25
  • Revenue Growth
  • HRMY 17.74
  • SIMO N/A
  • 52 Week Low
  • HRMY $26.47
  • SIMO $37.21
  • 52 Week High
  • HRMY $41.61
  • SIMO $91.20
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 30.87
  • SIMO 69.27
  • Support Level
  • HRMY $31.61
  • SIMO $87.46
  • Resistance Level
  • HRMY $32.84
  • SIMO $91.20
  • Average True Range (ATR)
  • HRMY 1.14
  • SIMO 2.63
  • MACD
  • HRMY -0.50
  • SIMO 0.62
  • Stochastic Oscillator
  • HRMY 9.08
  • SIMO 89.77

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: